Theravance Biopharma Inc
TBPH
Market Cap$518.51M
Close$
$10.75
8.6% upside
Current Fair Value
8.6% upsideUndervalued by 8.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $518.51 Million |
|---|---|
| Enterprise Value | $536.39 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.15 |
| Beta | 0.15 |
| Outstanding Shares | 49,306,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.06 |
|---|---|
| PEG | -10.99 |
| Price to Sales | 9.9 |
| Price to Book Ratio | 3.3 |
| Enterprise Value to Revenue | 8.33 |
| Enterprise Value to EBIT | -12.45 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.32 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Theravance Biopharma Inc
CEO: Rick Winningham